# DESMOPRESSIN ACETATE
> **ANDA216922** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2022-11-16
## Drug
- **FDA Application Number:** ANDA216922
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DESMOPRESSIN ACETATE
- **Generic name:** DESMOPRESSIN ACETATE
- **Active ingredients:** DESMOPRESSIN ACETATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2022-11-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216922)
---
*AI Analytics · CC0 1.0*